The SAMMPRIS trial is being done to determine whether intracranial stenting (a device inserted in a blood vessel in the brain) combined with intensive medical therapy is better than intensive medical therapy alone for preventing stroke or death in individuals who have had a stroke or TIA (mini stroke) caused by a narrowing in one of the arteries in the brain.